The Pyroptotic and Nonpyroptotic Roles of Gasdermins in Modulating Cancer Progression and Their Perspectives on Cancer Therapeutics

IF 2.9 4区 医学 Q3 IMMUNOLOGY
Sheng-Kai Hsu, Yi-En Chen, En-De Shu, Ching-Chung Ko, Wen-Tsan Chang, I.-Ling Lin, Chia-Yang Li, Rovelyn P. Gallego, Chien-Chih Chiu
{"title":"The Pyroptotic and Nonpyroptotic Roles of Gasdermins in Modulating Cancer Progression and Their Perspectives on Cancer Therapeutics","authors":"Sheng-Kai Hsu,&nbsp;Yi-En Chen,&nbsp;En-De Shu,&nbsp;Ching-Chung Ko,&nbsp;Wen-Tsan Chang,&nbsp;I.-Ling Lin,&nbsp;Chia-Yang Li,&nbsp;Rovelyn P. Gallego,&nbsp;Chien-Chih Chiu","doi":"10.1007/s00005-023-00678-9","DOIUrl":null,"url":null,"abstract":"<div><p>Gasdermins (GSDMs) are a protein family encoded by six paralogous genes in humans, including <i>GSDMA, GSDMB, GSDMC, GSDMD, GSDME</i> (also known as <i>DFNA5</i>), and <i>DFNB59</i> (also known as <i>pejvakin</i>). Structurally, members of the GSDM family possess a C-terminus (an autoinhibitory domain) and a positively charged N-terminus (a pore-forming domain) linked with divergent peptide linkers. Recently, GSDMs have been identified as key executors of pyroptosis (an immunogenic programmed cell death) due to their pore-forming activities on the plasma membrane when proteolytically cleaved by caspases or serine proteases. Accumulating studies suggest that chemoresistance is attributed to dysregulation of apoptotic machinery and that inducing pyroptosis to bypass aberrant apoptosis can potently resensitize apoptosis-resistant cancer to chemotherapeutics. Pyroptosis is initiated by pore formation and culminates with plasma membrane rupture; these processes enable the release of proinflammatory cytokines (e.g., IL-1β and IL-18) and damage-associated molecular patterns, which further modulate antitumor immunity within the tumor microenvironment. Although pyroptosis is considered a promising strategy to boost antitumor effects, it is also reported to cause unwanted tissue damage (e.g., gut damage and nephrotoxicity). Intriguingly, mounting evidence has uncovered nonpyroptotic roles of GSDMs in tumorigenesis, such as proliferation, invasion, metastasis, and drug resistance. Thus, this provides a rationale for GSDMs as potential therapeutic targets. Taken together, we shed unbiased light on the pyroptosis-dependent roles of GSDMs in cancer progression and highlighted how GSDMs modulate tumorigenesis in a pyroptosis-independent manner. It is evident that targeting GSDMs seems profound in cancer management; however, several problems require further investigation to target GSDMs from bench to bedside, which is elucidated in the discussion section.</p></div>","PeriodicalId":8389,"journal":{"name":"Archivum Immunologiae et Therapiae Experimentalis","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2023-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archivum Immunologiae et Therapiae Experimentalis","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00005-023-00678-9","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 1

Abstract

Gasdermins (GSDMs) are a protein family encoded by six paralogous genes in humans, including GSDMA, GSDMB, GSDMC, GSDMD, GSDME (also known as DFNA5), and DFNB59 (also known as pejvakin). Structurally, members of the GSDM family possess a C-terminus (an autoinhibitory domain) and a positively charged N-terminus (a pore-forming domain) linked with divergent peptide linkers. Recently, GSDMs have been identified as key executors of pyroptosis (an immunogenic programmed cell death) due to their pore-forming activities on the plasma membrane when proteolytically cleaved by caspases or serine proteases. Accumulating studies suggest that chemoresistance is attributed to dysregulation of apoptotic machinery and that inducing pyroptosis to bypass aberrant apoptosis can potently resensitize apoptosis-resistant cancer to chemotherapeutics. Pyroptosis is initiated by pore formation and culminates with plasma membrane rupture; these processes enable the release of proinflammatory cytokines (e.g., IL-1β and IL-18) and damage-associated molecular patterns, which further modulate antitumor immunity within the tumor microenvironment. Although pyroptosis is considered a promising strategy to boost antitumor effects, it is also reported to cause unwanted tissue damage (e.g., gut damage and nephrotoxicity). Intriguingly, mounting evidence has uncovered nonpyroptotic roles of GSDMs in tumorigenesis, such as proliferation, invasion, metastasis, and drug resistance. Thus, this provides a rationale for GSDMs as potential therapeutic targets. Taken together, we shed unbiased light on the pyroptosis-dependent roles of GSDMs in cancer progression and highlighted how GSDMs modulate tumorigenesis in a pyroptosis-independent manner. It is evident that targeting GSDMs seems profound in cancer management; however, several problems require further investigation to target GSDMs from bench to bedside, which is elucidated in the discussion section.

Abstract Image

气胚芽素在调节癌症进展中的热亡和非热亡作用及其在癌症治疗中的前景
Gasdermins (GSDMs)是由人类6个同源基因编码的蛋白家族,包括GSDMA、GSDMB、GSDMC、GSDMD、GSDME(也称为DFNA5)和DFNB59(也称为pejvakin)。在结构上,GSDM家族的成员具有一个c端(一个自抑制结构域)和一个带正电的n端(一个成孔结构域),与不同的肽连接物相连。最近,GSDMs已被确定为焦亡(一种免疫原性程序性细胞死亡)的关键执行者,这是由于它们在被半胱天蛋白酶或丝氨酸蛋白酶水解裂解时在质膜上形成孔的活性。越来越多的研究表明,化疗耐药归因于凋亡机制的失调,诱导凋亡绕过异常凋亡可以有效地使凋亡耐药的癌症对化疗药物重新敏感。热亡由孔隙形成开始,并以质膜破裂告终;这些过程使促炎细胞因子(如IL-1β和IL-18)和损伤相关分子模式的释放成为可能,从而进一步调节肿瘤微环境中的抗肿瘤免疫。虽然焦亡被认为是一种很有前途的增强抗肿瘤作用的策略,但也有报道称它会引起不必要的组织损伤(例如,肠道损伤和肾毒性)。有趣的是,越来越多的证据揭示了GSDMs在肿瘤发生中的非焦性作用,如增殖、侵袭、转移和耐药性。因此,这为GSDMs作为潜在的治疗靶点提供了理论依据。综上所述,我们公正地阐明了GSDMs在癌症进展中的焦热依赖作用,并强调了GSDMs如何以不依赖焦热的方式调节肿瘤发生。很明显,靶向GSDMs在癌症管理中似乎意义深远;然而,要将GSDMs从实验室应用到临床,还有几个问题需要进一步研究,讨论部分对此进行了阐述。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.90
自引率
0.00%
发文量
26
审稿时长
>12 weeks
期刊介绍: Archivum Immunologiae et Therapiae Experimentalis (AITE), founded in 1953 by Ludwik Hirszfeld, is a bimonthly, multidisciplinary journal. It publishes reviews and full original papers dealing with immunology, experimental therapy, immunogenetics, transplantation, microbiology, immunochemistry and ethics in science.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信